PRELUDE CAPITAL MANAGEMENT, LLC - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 78 filers reported holding TRANSLATE BIO INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q3 2020$5,000
-86.1%
400
-80.0%
0.00%
-100.0%
Q2 2020$36,000
+176.9%
2,000
+25.0%
0.00%
Q4 2019$13,000
+116.7%
1,600
+234.7%
0.00%
Q2 2019$6,0004780.00%
Other shareholders
TRANSLATE BIO INC shareholders Q4 2019
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,437,601$24,376,00011.53%
DAFNA Capital Management LLC 151,739$1,517,0000.62%
Bain Capital Public Equity Management, LLC 738,543$7,385,0000.52%
Baupost Group 6,491,287$62,393,0000.48%
Rock Springs Capital Management LP 1,009,179$10,092,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 276,639$2,766,0000.32%
Cormorant Asset Management, LP 454,550$4,546,0000.30%
Artal Group S.A. 600,000$6,000,0000.16%
Perceptive Advisors 500,000$5,000,0000.13%
ArrowMark Colorado Holdings LLC 367,744$3,677,0000.03%
View complete list of TRANSLATE BIO INC shareholders